Cost-effectiveness of psychedelic-assisted therapies for depression and post-traumatic stress disorder: A systematic review

Paper. Sheikhrobat MV, Jaberi N, Tahmasebi-Ghorrabi A et al.. Psychiatry Research, 13 Nov 2026.

Tags: Review, Psilocybin, MDMA, Depression, PTSD.

Weekly Science Digest, 13 Nov 2026 to 19 Nov 2026, finding 5: In brief

systematic review of seven economic evaluations: MDMA-assisted therapy for PTSD came out broadly cost-effective, with thinner data for psilocybin in depression

Read the original

—
Node—
Statuslive
Throughput—